EvodiaBio ApS
CVR 42569283 · Private limited company (ApS) · Active · Medium risk
EvodiaBio ApS is a Private limited company (ApS), founded on , based in Rødovre. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 68.6m and a net result of DKK -26.8m.
Bankruptcy risk for EvodiaBio ApS
1.0 × the average (1.41%) · higher risk than 75% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42569283
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (5 years)
- Address
- Islevdalvej 211
2610 Rødovre - Municipality
- Rødovre
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 138k
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 5 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 76.8% |
| Current ratio | 588% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -8.4m | DKK -10.0m |
| Net profit | DKK -26.8m | DKK -21.1m |
| Equity | DKK 68.6m | DKK 52.4m |
| Total assets | DKK 89.3m | DKK 55.0m |
| Cash | DKK 51.7m | – |
| Short-term debt | DKK 10.3m | – |
| Avg. employees | 23 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 167 | ||
| 1 Jan 2024 – 31 Dec 2024 | 147 | ||
| 1 Jan 2023 – 31 Dec 2023 | 144 | ||
| 1 Jan 2022 – 31 Dec 2022 | 137 | ||
| 28 Jul 2021 – 31 Dec 2021 | 180 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Simon Louis Théodore Armand Dusséaux | ||
| Board | Jarne Elleholm | Current | |
| Board | Flemming Besenbacher | Current | |
| Board | Andreas Helmut Fibig | Current | |
| Board | Anne Françoise Véronique Cabotin | Current | |
| Board | Johan Bitsch Nielsen | Current | |
| Board | Kyle Bjorn Teamey | Current | |
| Board | Victor Forman | ||
| Board | Sotirios Kampranis | ||
| Board | Simon Louis Théodore Armand Dusséaux | ||
| Board | Lauri Johannes Reuter | ||
| Board | Bart Van Hooland | ||
| Owner (5%) | BII Holdings A/S | Current | |
| Owner (5%) | NFT.VC Fund I Ky | Current | |
| Owner (5%) | Jarne Elleholm | Current | |
| Owner (5%) | FormanBiotech Holding ApS | Current | |
| Owner (5%) | STARFISH BIO ApS | Current | |
| Owner (5%) | SDBIO ApS | Current | |
| Owner (10%) | Danmarks Eksport- og Investeringsfond | Current | |
| Owner (15%) | RA Capital Planetary Health Fund, L.P. | Current | |
| Owner (20%) | LEEWARD ApS | ||
| Owner (25%) | FormanBiotech Holding ApS | ||
| Owner (25%) | STARFISH BIO ApS | ||
| Owner (25%) | SDBIO ApS | ||
| Owner (20%) | Jarne Elleholm | ||
| Owner (10%) | Jarne Elleholm | ||
| Owner (10%) | BioInnovation Institute Fonden | ||
| Owner (15%) | FormanBiotech Holding ApS | ||
| Owner (15%) | STARFISH BIO ApS | ||
| Owner (15%) | SDBIO ApS | ||
| Owner (5%) | NFT.VC Fund I Ky | ||
| Owner (5%) | Busiris Vermögensverwaltung GmbH | ||
| Owner (10%) | BII Holdings A/S | ||
| Owner (10%) | FormanBiotech Holding ApS | ||
| Owner (10%) | STARFISH BIO ApS | ||
| Owner (10%) | SDBIO ApS | ||
| Owner (5%) | Danmarks Eksport- og Investeringsfond | ||
| Owner (5%) | Busiris Vermögensverwaltung GmbH | ||
| Owner (5%) | March EXP I HoldCo D Limited | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | ||
| Founder | LEEWARD ApS | Current | |
| Founder | FormanBiotech Holding ApS | Current | |
| Founder | STARFISH BIO ApS | Current | |
| Founder | SDBIO ApS | Current |
The CEOs' other companies
Simon Louis Théodore Armand Dusséaux – 1 other companies
- SDBIO ApS Active
Address history (1 moves)
| Islevdalvej 211, 2610 Rødovre | |
| Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- Selskabet af 10. december 2021 A/S Bankrupt
- Dameca ApS Fusioneret
- ISLEVDAL INVEST III ApS Opløst
- Kaffe Bueno ApS Active
- O. & S. SCHRAMM TRADING A/S Fusioneret
Similar companies in Rødovre
- Joachim Vilstrup Holding ApS Rødovre
Questions and answers about EvodiaBio ApS
Has EvodiaBio ApS gone bankrupt?
No, EvodiaBio ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of EvodiaBio ApS?
Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.
Who is the auditor of EvodiaBio ApS?
EvodiaBio ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was EvodiaBio ApS founded?
EvodiaBio ApS was founded on 28 July 2021.
What is the equity of EvodiaBio ApS?
Equity was DKK 68.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.